Healthtech Startup Cent Raises Undisclosed Funding From OneFlow Holdings and South Park Commons

Why It Matters

Cent’s early‑detection technology could shift disease management toward preventive care, unlocking sizable market value for AI health platforms. Investor backing signals confidence in scalable, consumer‑focused diagnostics.

Key Takeaways

• Cent raised undisclosed round from OneFlow and South Park Commons.
• AI platform targets early detection of cancer, cardiac, metabolic diseases.
• Direct-to-consumer scans yielded 26% clinically meaningful findings.
• 3‑4% scans identified critical conditions needing immediate care.
• Oncology sector funding rising; Oncare, 4baseCare, Everhope secured rounds.

Pulse Analysis

The convergence of artificial intelligence and preventive healthcare is reshaping how early disease detection is approached. By leveraging deep learning algorithms on imaging and biometric data, platforms like Cent can identify subtle physiological changes that precede overt symptoms. This capability not only improves patient outcomes but also reduces long‑term treatment costs, positioning AI diagnostics as a strategic asset for insurers and providers seeking value‑based care models.

Cent’s direct‑to‑consumer model differentiates it from traditional hospital‑centric screening services. Offering at‑home or clinic‑based scans, the startup has already processed more than 1,500 examinations, reporting a notable 26% rate of clinically relevant findings. Such a high yield suggests robust algorithmic performance and a growing consumer willingness to engage in proactive health monitoring. The involvement of OneFlow and South Park Commons—both known for backing deep‑tech ventures—provides Cent with not just capital but also strategic guidance to scale operations across India’s fragmented healthcare landscape.

The funding wave across oncology and broader healthtech sectors reflects a broader market trend: investors are betting on technology that can democratize access to high‑quality diagnostics. Recent rounds for Oncare, 4baseCare, and Everhope illustrate a competitive pipeline of solutions targeting early cancer detection and chronic disease management. As regulatory frameworks evolve and reimbursement models adapt to digital health, startups like Cent are poised to capture a sizable share of the preventive care market, driving both clinical innovation and financial returns for stakeholders.

Deal Summary

Healthtech startup Cent announced it has raised an undisclosed amount of funding from OneFlow Holdings and South Park Commons. The Bengaluru‑based company is building an AI‑led early disease detection platform for cancers and other serious conditions. The round adds to growing investment in the healthtech oncology space.